Dr. Mora’s clinical interests include cardiovascular prevention, women’s health, and echocardiography. The author of over 90 peer-reviewed publications, Dr. Mora’s research focuses on risk factors and prevention of cardiovascular disease. She is actively involved with several randomized clinical trials and observational studies, and currently serves as the director of Core Biomarker Studied in the VITAminD and OmegA-3 Trial (VITAL). Most recently, she examined the association of novel lipid biomarkers and the development of cardiovascular disease in patients taking statins.